--- title: "Intellia grants 53,250 inducement RSUs to 13 new hires under 2024 plan" type: "News" locale: "en" url: "https://longbridge.com/en/news/291839083.md" description: "Intellia Therapeutics granted 53,250 inducement Restricted Stock Units (RSUs) to 13 new hires under its amended 2024 Inducement Plan on July 1, 2026. The grants consist of time-based RSUs tied to common stock, vesting one-third annually over three years, contingent upon continued service through each vesting date." datetime: "2026-07-06T20:05:42.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/291839083.md) - [en](https://longbridge.com/en/news/291839083.md) - [zh-HK](https://longbridge.com/zh-HK/news/291839083.md) generator: "portal-rs" --- # Intellia grants 53,250 inducement RSUs to 13 new hires under 2024 plan - Intellia Therapeutics awarded inducement grants on July 1, 2026 to 13 new employees under its 2024 Inducement Plan, as amended. \* Grants totaled 53,250 time-based RSUs tied to common stock, with one-third vesting each year over three years. \* Vesting depends on continued service through each vesting date. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Intellia Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607061605PRIMZONEFULLFEED9757514) on July 06, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) ### Related Stocks - [NTLA.US](https://longbridge.com/en/quote/NTLA.US.md) ## Related News & Research - [Intellia grants inducement RSUs for 38,200 shares to eight new employees](https://longbridge.com/en/news/295272227.md) - [Intellia Q2 2026 Earnings: Lonvo-z Moves Toward a BLA](https://longbridge.com/en/news/295103160.md) - [Goldman Sachs holds 5.5% stake in Alstom](https://longbridge.com/en/news/296498884.md) - [PharmAla Biotech says USPTO grants US patent for enantioselective MDMA, MBDB processes](https://longbridge.com/en/news/296608164.md) - [FLNG: Q2-2026 delivered strong earnings, high dividends, and reaffirmed guidance amid volatile LNG markets](https://longbridge.com/en/news/296304656.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**